NVTA - Invitae Corporation

NYSE - NYSE Delayed Price. Currency in USD
16.89
+0.77 (+4.78%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close16.12
Open16.17
Bid0.00 x 1300
Ask18.12 x 900
Day's Range16.06 - 16.93
52 Week Range4.35 - 18.38
Volume1,650,817
Avg. Volume1,261,631
Market Cap1.166B
Beta2.43
PE Ratio (TTM)N/A
EPS (TTM)-2.44
Earnings DateFeb 12, 2018 - Feb 16, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.75
Trade prices are not sourced from all markets
  • Is Invitae Corporation (NYSE:NVTA) Still A Cheap Healthcare Stock?
    Simply Wall St.14 hours ago

    Is Invitae Corporation (NYSE:NVTA) Still A Cheap Healthcare Stock?

    Invitae Corporation (NYSE:NVTA), a US$1.26b small-cap, is a healthcare company operating in an industry, which has experienced tailwinds from issues such as higher demand driven by an aging population andRead More...

  • Invitae to Present at the Ladenburg Thalmann 2018 Healthcare Conference
    PR Newswire3 days ago

    Invitae to Present at the Ladenburg Thalmann 2018 Healthcare Conference

    SAN FRANCISCO, Sept. 18, 2018 /PRNewswire/ -- Invitae Corporation (NVTA), one of the fastest growing genetics companies, today announced that Sean George, co-founder and chief executive officer of Invitae, will present at the Ladenburg Thalmann 2018 Healthcare Conference on Tuesday, October 2, 2018 at 9:00 a.m. Eastern / 6:00 a.m. Pacific in New York City. Invitae Corporation (NVTA) is a genetics company whose mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people.

  • PR Newswire10 days ago

    Invitae Appoints Chitra Nayak to its Board of Directors

    SAN FRANCISCO, Sept. 11, 2018 /PRNewswire/ -- Invitae Corporation (NVTA), one of the fastest growing genetics companies, announced the appointment of Chitra Nayak to its Board of Directors, effective September 10, 2018. "We are pleased to welcome Chitra Nayak to our board of directors and look forward to working with her, taking full advantage of her considerable track record of helping companies achieve transformational growth to scale and innovate globally," said Sean George, co-founder and chief executive officer of Invitae. "Chitra has deep operational and commercial leadership expertise in growing market share and strengthening industry leadership positions for rapidly growing companies, including organizations like ours that are transforming highly competitive industries.

  • Implied Volatility Surging for Invitae (NVTA) Stock Options
    Zacks14 days ago

    Implied Volatility Surging for Invitae (NVTA) Stock Options

    Investors need to pay close attention to Invitae (NVTA) stock based on the movements in the options market lately.

  • GlobeNewswire16 days ago

    Factors of Influence in 2018, Key Indicators and Opportunity within Destination XL Group, Invitae, Federated National Holding, Bridge, QCR, and Kelly Services — New Research Emphasizes Economic Growth

    NEW YORK, Sept. 05, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...

  • Here's Why Invitae Rose 67.5% in August
    Motley Fool16 days ago

    Here's Why Invitae Rose 67.5% in August

    The genetic-testing leader reported strong second-quarter 2018 earnings results.

  • Why Invitae Stock Rose 23% in Week Ended August 24
    Market Realist24 days ago

    Why Invitae Stock Rose 23% in Week Ended August 24

    On August 24, Invitae (NVTA) stock closed at $12.56, which represents a ~4.75% growth from its prior day’s close of $11.99. It hit its 52-week high of $12.75 on August 24. For the week ended August 24, Invitae stock closed at $12.56, which represents a ~23% rise from its prior week’s close of $10.21 on August 17. Invitae delivered solid growth in the second quarter of 2018 when it reported revenues of $37.3 million compared to $14.3 million in Q2 2017.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of NVTA earnings conference call or presentation 7-Aug-18 8:30pm GMT

    Q2 2018 Invitae Corp Earnings Call

  • GlobeNewswirelast month

    Investor Expectations to Drive Momentum within Global Medical REIT, Cyclacel Pharmaceuticals, Super Micro Computer, Kelly Services, Invitae, and ScanSource — Discovering Underlying Factors of Influence

    NEW YORK, Aug. 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Global ...

  • Here's Why Invitae Corp Rose as Much as 20.6% Today
    Motley Foollast month

    Here's Why Invitae Corp Rose as Much as 20.6% Today

    The genetic testing leader delivered another strong quarter of growth.

  • Invitae (NVTA) Reports Q2 Loss, Tops Revenue Estimates
    Zackslast month

    Invitae (NVTA) Reports Q2 Loss, Tops Revenue Estimates

    Invitae (NVTA) delivered earnings and revenue surprises of 16.07% and 21.54%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Presslast month

    Invitae: 2Q Earnings Snapshot

    The San Francisco-based company said it had a loss of 47 cents per share. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was ...

  • Invitae Reports More than 160% Annual Revenue Growth Driven by Nearly 140% Annual Growth in Volume in Second Quarter 2018
    PR Newswirelast month

    Invitae Reports More than 160% Annual Revenue Growth Driven by Nearly 140% Annual Growth in Volume in Second Quarter 2018

    -- Raising annual revenue guidance amid strong quarter performance -- -- Q2 2018 gross profit of $16.9M up from $3.8M in Q2 2017 -- -- Management hosting conference call and webcast today at 4:30pm Eastern/1:30pm ...

  • ACCESSWIRElast month

    Invitae Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 7, 2018 / Invitae Corp. (NYSE: NVTA ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 4:30 PM Eastern Time. To listen ...

  • Cerner (CERN) Looks Good: Stock Adds 6.2% in Session
    Zacks2 months ago

    Cerner (CERN) Looks Good: Stock Adds 6.2% in Session

    Cerner (CERN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

  • Invitae (NVTA): Moving Average Crossover Alert
    Zacks2 months ago

    Invitae (NVTA): Moving Average Crossover Alert

    Invitae Corporation (NVTA) is looking like an interesting pick from a technical perspective

  • Invitae to announce second quarter 2018 Financial Results on August 7, 2018
    PR Newswire2 months ago

    Invitae to announce second quarter 2018 Financial Results on August 7, 2018

    SAN FRANCISCO, July 24, 2018 /PRNewswire/ -- Invitae Corporation (NVTA), one of the fastest growing genetics companies, today announced that it will report its second quarter 2018 financial results on Tuesday, August 7, 2018 and will host a conference call and webinar that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent highlights. The dial-in numbers for the conference call are (866) 393-4306 for domestic callers and (734) 385-2616 for international callers, and the reservation number for both is 3497996. Invitae Corporation (NVTA) is a genetic testing and information company.

  • ACCESSWIRE2 months ago

    Free Stock Performance Review on IQVIA Holdings and Three Additional Medical Research Stocks

    LONDON, UK / ACCESSWIRE / July 16, 2018 / If you want a free Stock Review on IQV sign up now at www.wallstequities.com/registration. WallStEquities.com has selected the following Medical Laboratories and Research stocks for review this morning: iKang Healthcare Group Inc. (NASDAQ: KANG), Invitae Corp. (NYSE: NVTA), IQVIA Holdings Inc. (NYSE: IQV), and Laboratory Corp. of America Holdings (NYSE: LH).

  • Here's Why Invitae Dropped 14.9% in 2018 (So Far)
    Motley Fool3 months ago

    Here's Why Invitae Dropped 14.9% in 2018 (So Far)

    The genetic testing leader is growing at a healthy clip, but still burning through piles of cash.

  • Invitae Expands Reproductive Health Offering with Launch of Comprehensive Genetic Carrier Screening
    PR Newswire3 months ago

    Invitae Expands Reproductive Health Offering with Launch of Comprehensive Genetic Carrier Screening

    SAN FRANCISCO, June 25, 2018 /PRNewswire/ -- Invitae Corporation (NVTA), one of the fastest growing genetics companies, today announced the launch of the Invitae Carrier Screen, a comprehensive test designed to provide affordable, accessible information on genetic changes that pose a risk for parents of having a child with an inherited genetic disorder. "By providing affordable, comprehensive, high-quality genetic information, Invitae carrier testing can help parents-to-be have the information they need to make appropriate health decisions when starting a family," said Robert Nussbaum, M.D., chief medical officer of Invitae.

  • Invitae Study of 143,000 Patients Shows Importance of Routinely Including Deletion and Duplication Detection with Sequencing in Genetic Testing
    PR Newswire3 months ago

    Invitae Study of 143,000 Patients Shows Importance of Routinely Including Deletion and Duplication Detection with Sequencing in Genetic Testing

    SAN FRANCISCO, June 13, 2018 /PRNewswire/ -- Researchers from Invitae, one of the fastest growing genetics companies, today published findings from the largest analysis to date of genetic testing to identify deletions and duplications involving single genes using next-generation sequencing (NGS) techniques. The study found that these changes, also called exonic copy number variants (CNVs), are present in a substantial number of patients and suggested that CNV testing should be universally used in clinical genetic testing. With few exceptions, these types of exonic CNVs are not typically detectable or reported from cytogenetic methods such as whole-genome chromosomal microarrays.

  • ACCESSWIRE4 months ago

    Stock Performance Review on Exact Sciences and Three Other Medical Research Stocks

    Gains were broad based as eight out of nine sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Medical Laboratories & Research stocks: DexCom Inc. (NASDAQ: DXCM), Exact Sciences Corp. (NASDAQ: EXAS), iKang Healthcare Group Inc. (NASDAQ: KANG), and Invitae Corp. (NYSE: NVTA).

  • Invitae to Present at the William Blair 2018 Growth Stock Conference
    PR Newswire4 months ago

    Invitae to Present at the William Blair 2018 Growth Stock Conference

    SAN FRANCISCO, May 30, 2018 /PRNewswire/ -- Invitae Corporation (NVTA), one of the fastest growing genetics companies, today announced that Sean George, co-founder and chief executive officer of Invitae, will present at the William Blair 2018 Growth Stock Conference on Tuesday, June 12, 2018 at 4:10 p.m. Central / 5:10 p.m. Eastern / 2:10 p.m. Pacific in Chicago. Invitae Corporation (NVTA) is a genetics company whose mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae's goal is to aggregate most of the world's genetic tests into a single service with higher quality, faster turnaround time and lower prices.

  • Why This Genetics Stock Could Be a Gold Mine for Growth Investors
    Motley Fool4 months ago

    Why This Genetics Stock Could Be a Gold Mine for Growth Investors

    Invitae reported $1.6 million in revenue in 2014. This year it expects more than $130 million.

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of NVTA earnings conference call or presentation 9-May-18 8:30pm GMT

    Q1 2018 Invitae Corp Earnings Call